Hennion & Walsh Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,580
| Closed | -$1.09M | – | 925 |
|
|
2025
Q1 | $1.09M | Sell |
32,580
-7,510
| -19% | -$252K | 0.05% | 455 |
|
|
2024
Q4 | $2.05M | Sell |
40,090
-745
| -2% | -$38.1K | 0.09% | 283 |
|
|
2024
Q3 | $2.09M | Sell |
40,835
-509
| -1% | -$26K | 0.1% | 272 |
|
|
2024
Q2 | $1.85M | Buy |
41,344
+3,257
| +9% | +$146K | 0.1% | 266 |
|
|
2024
Q1 | $1.78M | Buy |
38,087
+927
| +2% | +$43.4K | 0.1% | 282 |
|
|
2023
Q4 | $1.32M | Buy |
37,160
+2,597
| +8% | +$92.4K | 0.08% | 340 |
|
|
2023
Q3 | $1.03M | Buy |
34,563
+16,327
| +90% | +$486K | 0.07% | 352 |
|
|
2023
Q2 | $329K | Buy |
+18,236
| New | +$329K | 0.02% | 624 |
|